Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement of Virpax Pharmaceuticals, Inc. on Form S-8 to be filed on or about May 6, 2022 of our report dated March 31, 2022, on our audits of the financial statements as of December 31, 2021 and 2020 and for each of the years then ended, which report was included in the Annual Report on Form 10-K filed March 31, 2022.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Philadelphia, Pennsylvania
May 6, 2022